Viewing Study NCT01788358


Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-03-02 @ 4:55 PM
Study NCT ID: NCT01788358
Status: COMPLETED
Last Update Posted: 2017-10-24
First Post: 2013-02-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-02-14
Start Date Type: ACTUAL
Primary Completion Date: 2014-05-01
Primary Completion Date Type: ACTUAL
Completion Date: 2014-05-01
Completion Date Type: ACTUAL
First Submit Date: 2013-02-07
First Submit QC Date: None
Study First Post Date: 2013-02-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2015-07-21
Results First Submit QC Date: None
Results First Post Date: 2015-08-17
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2015-07-01
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2017-09-22
Last Update Post Date: 2017-10-24
Last Update Post Date Type: ACTUAL